Aeolus Pharmaceuticals, Inc.
OTC: AOLS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Christopher Stanley
- Employees
- 4
- Headquarters
- Mission Viejo, United States
- IPO year
- 1996
- Market cap
- $15.2K
- Website
- https://www.aeoluspharma.com
Loading AOLS…
Loading profile data…Frequently asked questions about AOLS
What does Aeolus Pharmaceuticals, Inc. (AOLS) do?
Aeolus Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the development of innovative therapeutic compounds. Operating within the United States, the company's research pipeline addresses a diverse range of critical medical challenges, including biodefense, fibrotic conditions, oncology, infectious diseases, and central nervous s...
Where does AOLS trade?
Aeolus Pharmaceuticals, Inc. (AOLS) trades on the Other OTC.
What sector is AOLS in?
Aeolus Pharmaceuticals, Inc. (AOLS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Aeolus Pharmaceuticals, Inc.?
Christopher Stanley is the chief executive officer of Aeolus Pharmaceuticals, Inc. (AOLS).
Where is Aeolus Pharmaceuticals, Inc. headquartered?
Aeolus Pharmaceuticals, Inc. is headquartered in United States.
Does AOLS pay a dividend?
Aeolus Pharmaceuticals, Inc. (AOLS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AOLS go public?
Aeolus Pharmaceuticals, Inc. (AOLS) completed its initial public offering in 1996.